Hashimoto's thyroiditis epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 21: | Line 21: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Needs content]] | |||
[[Category: | |||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
Revision as of 20:04, 7 July 2016
Hashimoto's thyroiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hashimoto's thyroiditis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Hashimoto's thyroiditis epidemiology and demographics |
FDA on Hashimoto's thyroiditis epidemiology and demographics |
CDC on Hashimoto's thyroiditis epidemiology and demographics |
Hashimoto's thyroiditis epidemiology and demographics in the news |
Blogs on Hashimoto's thyroiditis epidemiology and demographics |
Risk calculators and risk factors for Hashimoto's thyroiditis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
This disorder is believed to be the most common cause of primary hypothyroidism in North America. It occurs far more often in women than in men (10:1 to 20:1), and is most prevalent between 45 and 65 years of age.
In European countries an atrophic form of autoimmune thyroiditis (Ord's thyroiditis) is more common than Hashimoto's thyroiditis.
It affects between 0.1% and 5% of all adults in Western countries.
Various autoantibodies may be present against thyroid peroxidase, thyroglobulin and TSH receptors, although a small percentage of patients may have none of these antibodies present. A percentage of the population may also have these antibodies without developing Hashimoto's thyroiditis.